Information Update - Risk Of Serious Liver Injury Associated With Hepatitis C Treatments: Holkira Pak And Technivie

Recall Summary Health Canada has issued an information update regarding Holkira Pak and Technivie, which are medications used to treat Hepatitis C, due to a risk of serious liver injury in patients. The recall affects people across Canada who are taking these specific Hepatitis C treatments. Patients currently using these products should consult with their healthcare provider about this safety concern.

Category

consumer product recall

Country

Canada

Agency

HC-PRODUCTS

Recall date

2015-11-10

Status

Closed

Distribution

Canada-wide

Official recall notice from HC-PRODUCTS

Recall details on Nibble Recalls: https://trynibble.app/recalls/c20cabc5-94f0-45bf-82ab-c4099049a797